The 6-O-sulfate ester of morphine (M6S) has previously been shown to be an analgesic with greater potency and fewer side effects than morphine. However, being a sulfate ester derivative of morphine, the question exists as to whether this compound is stable in biological fluids and tissues with regard to pH- and esterase-mediated degradation. To date, no studies have focused on the stability profile of M6S across the physiologically relevant pH range of 1.2-7.4. In addition, the stability of M6S is not known in rat plasma and rat brain homogenate, or in simulated rat gastric and intestinal fluids. This study determines the stability profile of M6S (utilized as the sodium salt) and demonstrates that M6S is highly stable and resilient to either enzymatic- or pH-dependent hydrolysis in vitro.

Download full-text PDF

Source
http://dx.doi.org/10.1002/bmc.3957DOI Listing

Publication Analysis

Top Keywords

stability profile
8
profile m6s
8
m6s
5
stability
4
stability studies
4
studies potent
4
potent opioid
4
opioid analgesic
4
analgesic morphine-6-o-sulfate
4
morphine-6-o-sulfate buffers
4

Similar Publications

Background: There are no cures for Alzheimer's disease (AD), a progressive neurodegenerative disorder characterized by elevation of beta-amyloid and tau proteins besides neuronal death and causing cognitive impairment. Phosphodiesterase 5 (PDE5) is a cyclic guanosine monophosphate-degrading enzyme involved in numerous biological pathways including those relevant to memory formation. PDE5 inhibition offers the potential to attenuate AD progression by acting at the downstream level of beta-amyloid and tau elevation.

View Article and Find Full Text PDF

Breakthrough Psoriasis in Patients Receiving Biologicals.

Psoriasis (Auckl)

January 2025

Department of Dermatology and Venerology, CHU of Sart Tilman, University of Liège B-4000, Liège, Belgium.

Background: Biological therapies, including TNF-alpha, IL12/23, IL17 and IL23 antagonists, adequately control a very high number of patients with moderate-to-severe psoriasis with an excellent long-term safety profile. However, on occasion, patients on biological therapy with stabilized disease or complete remission report episodes of sudden breakthrough psoriasis.

Aim: To study prospectively in a monocentric tertiary setting, the clinical characteristics of patients presenting a sudden breakthrough psoriasis although completely stabilized (PASI 90-100) under biological therapy.

View Article and Find Full Text PDF

Globally stable blowup profile for supercritical wave maps in all dimensions.

Calc Var Partial Differ Equ

January 2025

Faculty of Mathematics, Bielefeld University, Universitätsstr. 25, 33615 Bielefeld, Germany.

We consider wave maps from the -dimensional Minkowski space into the -sphere. It is known from the work of Bizoń and Biernat (Commun Math Phys 338(3): 1443-1450, 2015) that in the energy-supercritical case, i.e.

View Article and Find Full Text PDF

Identification of potential MMP-8 inhibitors through virtual screening of natural product databases.

In Silico Pharmacol

January 2025

College of Chemistry and Chemical Engineering, China University of Petroleum, Qingdao, 266580 China.

Matrix metalloproteinase-8 (MMP-8), a type II collagenase, is a key enzyme in the degradation of collagens and is implicated in various pathological processes, making it a promising target for drug discovery. Despite advancements in the development of MMP-8 inhibitors, concerns over potential adverse effects persist. This study aims to address these concerns by focusing on the development of novel compounds with improved safety profiles while maintaining efficacy.

View Article and Find Full Text PDF

Machine learning (ML) has emerged as a transformative tool in drug delivery, particularly in the design and optimization of liposomal formulations. This review focuses on the intersection of ML and liposomal technology, highlighting how advanced algorithms are accelerating formulation processes, predicting key parameters, and enabling personalized therapies. ML-driven approaches are restructuring formulation development by optimizing liposome size, stability, and encapsulation efficiency while refining drug release profiles.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!